Table 5.
Biomarkers | Sub-Groups | Univariate Beta coefficient | p value | Multivariate Beta coefficient | p value |
---|---|---|---|---|---|
Cu2+ (μg/dL) | Diabetic Obese (DO) | 0.266 | <0.0001* | 0.315 | 0.103 |
Diabetic Non-Obese (DNO) | −0.103 | <0.0001* | −0.144 | 0.272 | |
Non-Diabetic Obese (NDO) | −0.114 | <0.0001* | 0.045 | 0.825 | |
Mn2+ (μg/L) | Diabetic Obese (DO) | 0.133 | 0.059 | – | – |
Diabetic Non-Obese (DNO) | −0.100 | <0.0001* | −0.078 | 0.505 | |
Non-Diabetic Obese (NDO) | −0.262 | <0.0001* | −0.206 | 0.217 | |
Mg2+ (mg/dL) | Diabetic Obese (DO) | −0.248 | <0.0001* | 0.507 | <0.0001* |
Diabetic Non-Obese (DNO) | 0.375 | <0.0001* | −0.521 | 0.003* | |
Non-Diabetic Obese (NDO) | −0.461 | <0.0001* | −0.212 | 0.281 | |
Fe2+ (μg/dl) | Diabetic Obese (DO) | −0.119 | <0.0001* | 0.025 | 0.906 |
Diabetic Non-Obese (DNO) | −0.045 | <0.0001* | −0.066 | 0.575 | |
Non-Diabetic Obese (NDO) | −0.168 | <0.0001* | 0.139 | 0.484 | |
Se2+ (μg/L) | Diabetic Obese (DO) | −0.054 | <0.0001* | −0.166 | 0.416 |
Diabetic Non-Obese (DNO) | 0.091 | <0.0001* | 0.209 | 0.159 | |
Non-Diabetic Obese (NDO) | −0.116 | <0.0001* | 0.261 | 0.237 | |
Cr2+ (μg/L) | Diabetic Obese (DO) | 0.062 | <0.0001* | 0.109 | 0.557 |
Diabetic Non-Obese (DNO) | −0.068 | <0.0001* | −0.075 | 0.563 | |
Non-Diabetic Obese (NDO) | 0.103 | <0.0001* | 0.080 | 0.613 | |
Zn2+ (μg/dL) | Diabetic Obese (DO) | −0.004 | <0.0001* | −0.038 | 0.865 |
Diabetic Non-Obese (DNO) | −0.067 | <0.0001* | −0.229 | 0.127 | |
Non-Diabetic Obese (NDO) | −0.299 | <0.0001* | −0.452 | 0.073 | |
Insulin (μIU/ml) | Diabetic Obese (DO) | 0.034 | <0.0001* | −0.093 | 0.627 |
Diabetic Non-Obese (DNO) | 0.078 | <0.0001* | 0.184 | 0.118 | |
Non-Diabetic Obese (NDO) | 0.093 | <0.0001* | 0.162 | 0.338 |
Abbreviations: DO Diabetic Obese, DNO Diabetic Non-Obese, DNO Diabetic Non-Obese. Univariate and multivariate regression analysis was done to predict the independent marker. *p value <0.05 is considered statistically significant